Armistice Capital Master Fund's Net Worth
Armistice Capital Master Fund's net worth is estimated to be at least $4,871,568.92 as of 12/23/2024. CoreStreet's estimation of Armistice Capital Master Fund's net worth is based on their sale of stock and current holding of stock.
Armistice Capital Master Fund is Major Shareholder at Tenax Therapeutics Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 34,903 units of TENX stock on 08/26/2020. Their biggest sale was on 08/20/2018 when they sold 1,256,000 units of Cassava Sciences Inc stock for $1,281,120.00. They typically trade 3 times per year.
Total value of insider buys:
- $2,747,408.70
Total value of insider sells:
- $2,124,160.22
Most recent insider trade:
- Aug. 26, 2020
Armistice Capital Master Fund's Insider Trading History
| Tenax Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 26, 2020 | Major Shareholder | 34,903 | $1.51 | Buy | $52,703.53 |
| Aytu BioScience Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 20, 2019 | Major Shareholder | 78,788 | $0.90 | Buy | $70,909.20 |
| Vaxart Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 7, 2019 | Major Shareholder | 200,000 | $0.35 | Buy | $70,000.00 |
Oct. 7, 2019 | Major Shareholder | 564,000 | $0.36 | Buy | $203,040.00 |
Oct. 3, 2019 | Major Shareholder | 436,000 | $0.35 | Buy | $152,600.00 |
Sept. 30, 2019 | Major Shareholder | 7,333,333 | $0.29 | Buy | $2,126,666.57 |
| Achieve Life Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 11, 2019 | Major Shareholder | 12,813 | $3.80 | Buy | $48,689.40 |
| Bio Path Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 18, 2019 | Major Shareholder | 64,457 | $2.66 | Sell | $171,455.62 |
| Cassava Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 3, 2018 | Major Shareholder | 512,660 | $1.31 | Sell | $671,584.60 |
Aug. 20, 2018 | Major Shareholder | 1,256,000 | $1.02 | Sell | $1,281,120.00 |
| Alimera Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 6, 2018 | Major Shareholder | 20,000 | $1.14 | Buy | $22,800.00 |